FibroGen (NASDAQ:FGEN – Get Free Report) and Roche (OTCMKTS:RHHBY – Get Free Report) are both medical companies, but which is the better business? We will contrast the two businesses based on the ...
Dealbreaker on MSN16h
AstraZeneca Secures China Rights to Anemia Drug, Buying FibroGen Unit in $160M DealBy selling its China business to AstraZeneca, FibroGen can focus on developing a prostate cancer drug and potentially ...
The week has ended with a flurry of M&A in the drug industry, with Cosette Pharmaceuticals agreeing to buy Australia's Mayne ...
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
The health sector is facing significant changes, with the FDA restricting language, New York suing e-cigarette makers, AstraZeneca expanding in China, Eli Lilly stockpiling weight-loss drugs, Teva and ...
Vontobel Holding Ltd. grew its stake in Sprott Uranium Miners ETF (NYSEARCA:URNM – Free Report) by 12.2% in the 4th quarter, according to its most recent filing with the Securities and Exchange ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback